Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia

Naykky Singh Ospina; Victor M. Montori; R. Retnakaran

doi:10.7326/ACPJC-2015-162-2-006

Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA_1c without increasing hypoglycemia

Naykky Singh Ospina, Victor M. Montori, R. Retnakaran

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	JC6
Journal	Annals of internal medicine
Volume	162
Issue number	2
DOIs	https://doi.org/10.7326/ACPJC-2015-162-2-006
State	Published - Jan 20 2015

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/ACPJC-2015-162-2-006

Cite this

@article{2dea3663a0a940a5b5ee25d5fd49c1cb,

title = "Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia",

author = "Ospina, {Naykky Singh} and Montori, {Victor M.} and R. Retnakaran",

year = "2015",

month = jan,

day = "20",

doi = "10.7326/ACPJC-2015-162-2-006",

language = "English (US)",

volume = "162",

pages = "JC6",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "2",

}

TY - JOUR

T1 - Review

T2 - In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia

AU - Ospina, Naykky Singh

AU - Montori, Victor M.

AU - Retnakaran, R.

PY - 2015/1/20

Y1 - 2015/1/20

UR - http://www.scopus.com/inward/record.url?scp=84921672902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921672902&partnerID=8YFLogxK

U2 - 10.7326/ACPJC-2015-162-2-006

DO - 10.7326/ACPJC-2015-162-2-006

M3 - Comment/debate

C2 - 25599366

AN - SCOPUS:84921672902

SN - 0003-4819

VL - 162

SP - JC6

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 2

ER -

Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA_1c without increasing hypoglycemia